JMP Securities Reiterates Market Outperform Rating for Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH)‘s stock had its “market outperform” rating restated by equities researchers at JMP Securities in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $30.00 price target on the stock, down from their prior price target of $31.00. JMP Securities’ price objective suggests a potential upside of 25.05% from the stock’s current price.

Other research analysts have also issued reports about the stock. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of “Hold” and an average price target of $29.14.

Option Care Health Price Performance

NASDAQ:OPCH opened at $23.99 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a fifty day simple moving average of $23.10 and a 200 day simple moving average of $27.70. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The stock has a market capitalization of $4.08 billion, a PE ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Westfield Capital Management Co. LP boosted its stake in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares during the period. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after acquiring an additional 25,905 shares during the period. Victory Capital Management Inc. grew its holdings in shares of Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares in the last quarter. Edgestream Partners L.P. increased its position in shares of Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, Pier Capital LLC raised its stake in Option Care Health by 88.4% in the third quarter. Pier Capital LLC now owns 231,884 shares of the company’s stock valued at $7,258,000 after purchasing an additional 108,783 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.